Work

Penetrating the central nervous system sanctuary of KRAS, a target once thought “undruggable”

Year: 2023

Type: article

Source: Translational Lung Cancer Research

DOI: 10.21037/tlcr-23-71

Authors: Misako Nagasaka, Asfar S. Azmi

Institutions: St. Marianna University School of Medicine, University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funders: Eli Lilly and Company, Pfizer, AstraZeneca, Sky Foundation, Eisai, National Institutes of Health, Genentech, EMD Serono, National Cancer Institute, Daiichi Sankyo Europe, H2020 European Research Council

Awards: G3208868322, G9000019950

OpenAlex ID: W4362689400

FWCI: 0.482

Cites: 21

Cited by: 3

Related to: 10